Cleveland

The trials here

What the 2 trials at this site are about, from their registry records.

Conditions

• Lupus (SLE)2 trials
• Dermatomyositis and polymyositis (myositis)1 trial
• Rheumatoid arthritis1 trial
• Systemic sclerosis (scleroderma)1 trial

Phase

• Phase 11 trial
• Phase 31 trial

Status

• Active, not recruiting2 trials

Lead sponsor

• Bristol-Myers Squibb1 trial
• Juno Therapeutics, Inc., a Bristol-Myers Squibb Company1 trial

Running trials

• Active, not recruiting

  A Study of CC-97540, CD-19-Targeted Nex-T CAR T Cells, in Participants With Severe, Refractory Autoimmune Diseases (Breakfree-1)

  NCT05869955· Phase 1· Juno Therapeutics, Inc., a Bristol-Myers Squibb Company· Source

• Active, not recruiting

  A Study to Evaluate Effectiveness and Safety of Deucravacitinib (BMS-986165) Compared With Placebo in Participants With Active Systemic Lupus Erythematosus

  NCT05620407· Phase 3· Bristol-Myers Squibb· Source